300 followers
A review of data for Ibrance for met #BreastCancer. https://t.co/9EnjdKINZO
A review of data for Ibrance for met #BreastCancer. https://t.co/9EnjdKINZO
Palbociclib: A Review in HR-Positive, HER2-Negative, Advanced or Metastatic Breast Cancer. https://t.co/sSMLSMMR77 #breastcancer
Our latest @AdisJournals Drug Evaluation on #Palbociclib in HR+/HER2-Breast Cancer https://t.co/uXvWIkqrSs #breastcancer #cancer